Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2018-07
-
Apigenin: Applied Workflows for Cancer and Neuroprotection R
2026-05-08
Apigenin (5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one) offers a unique dual role as both a histone deacetylase inhibitor for cancer research and a neuroprotective flavonoid in Alzheimer's models. Explore data-driven protocols, troubleshooting strategies, and the latest insights from reference studies to accelerate your experimental outcomes.
-
Sodium Ascorbate: Mechanisms and Evidence in Cancer Research
2026-05-08
Sodium Ascorbate, a mineral salt of ascorbic acid, exhibits enhanced bioavailability and induces necrotic tumor cell death via intracellular ROS generation. This article provides evidence-based protocols and clarifies mechanistic insights for its use in cancer research.
-
Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S
2026-05-07
This study introduces a gastric cancer assembloid platform integrating patient-matched tumor organoids and stromal cell subpopulations, producing preclinical models that more faithfully recapitulate primary tumor heterogeneity and microenvironment. The findings reveal how stromal diversity modulates gene expression and drug response, informing personalized therapeutic strategies and drug resistance research.
-
Applied Workflows for JNJ-26481585 (Quisinostat) in Cancer M
2026-05-07
Harnessing the potent HDAC inhibition of JNJ-26481585 (Quisinostat) enables researchers to drive apoptosis, reverse drug resistance, and dissect epigenetic mechanisms in challenging tumor models. This article delivers protocol-ready guidance, troubleshooting strategies, and unique insights inspired by the latest TRIM21-ERK1/2 research.
-
MRT68921 ULK1/2 Inhibitor: Reproducible Autophagy Blockade (
2026-05-06
This article addresses common laboratory challenges in autophagy research and demonstrates how MRT68921 dual autophagy kinase ULK1/2 inhibitor (SKU B6174) achieves reproducible, selective autophagy inhibition. Evidence-based scenarios guide biomedical researchers in optimizing assay workflows, interpreting kinase selectivity, and making informed reagent choices for robust LC3 flux and ATG13 phosphorylation blockade.
-
TNF-alpha Recombinant Murine Protein: Decoding Active Cell D
2026-05-06
Explore how TNF-alpha recombinant murine protein enables precise dissection of apoptosis and inflammation mechanisms. This article uniquely bridges advanced mechanistic insights with practical assay optimization, highlighting the latest evidence on active cell death signaling.
-
IGFBP2-THBS1 Axis Mediates GH-Induced Bone Growth in ISS
2026-05-05
This study identifies a novel IGFBP2-THBS1 interaction as a critical mediator of recombinant human growth hormone (GH, somatotropin) therapy in idiopathic short stature (ISS). By elucidating how GH regulates chondrocyte proliferation via the IGF-1 pathway, the findings offer new mechanistic targets for optimizing bone growth interventions.
-
BIBR 1532: Telomerase Inhibitor Workflows for Cancer Researc
2026-05-05
BIBR 1532 stands out as a selective telomerase inhibitor, allowing researchers to dissect telomerase-driven cancer phenotypes with precision. This in-depth guide bridges cutting-edge literature with practical protocols, enhancing experimental reliability in telomerase activity and apoptosis assays.
-
Okadaic Acid (A4540): Practical Guide for PP1/PP2A Inhibitio
2026-05-04
Okadaic acid is a high-affinity inhibitor of serine/threonine phosphatases PP1 and PP2A, enabling precise dissection of phosphorylation-dependent pathways in cell biology and biochemical assays. It is best suited for applications requiring specific, nanomolar-range phosphatase inhibition and is not recommended for protocols demanding broad-spectrum phosphatase suppression or solvent interchangeability.
-
5-hme-dCTP: Driving Precision Epigenetic Discovery in Plants
2026-05-04
This thought-leadership article explores how 5-hme-dCTP (5-Hydroxymethyl-2’-deoxycytidine-5’-Triphosphate) enables a new era of epigenetic DNA modification research, with a special focus on plant drought response and gene regulation. We bridge mechanistic insight, recent translational breakthroughs, and strategic recommendations for researchers seeking actionable, high-resolution tools. The discussion integrates emerging evidence on 5hmC’s bifunctional regulatory role, competitive assay design, and best practices for leveraging APExBIO’s validated 5-hme-dCTP in advanced experimental workflows.
-
BGJ398 (NVP-BGJ398): Optimizing FGFR Inhibition in Oncology
2026-05-03
BGJ398 (NVP-BGJ398) empowers researchers to precisely dissect FGFR signaling and drive apoptosis induction in cancer cells. This article delivers applied assay workflows, troubleshooting insights, and new interpretation tools based on the latest comparative developmental biology findings.
-
Human iPSC Sensory Neurons Model HSV-1 Latency and Reactivat
2026-05-02
This study establishes a robust protocol for differentiating human inducible pluripotent stem cells (hiPSCs) into functional sensory neurons and validates their use as an in vitro model for latent infection and reactivation by herpes simplex virus 1 (HSV-1). The model enables mechanistic studies of HSV-1 latency in human neurons, supporting translational research into therapeutic strategies.
-
Enhanced In-Vitro Activity of Temafloxacin Versus Gram-Posit
2026-05-01
This study systematically evaluates temafloxacin, a fluoroquinolone broad-spectrum antibacterial agent, for its in-vitro efficacy against Gram-positive bacteria from bloodstream infections. The research demonstrates that temafloxacin surpasses older quinolones in potency against Staphylococcus aureus and Streptococcus pneumoniae, highlighting its potential for translational and resistance research.
-
Micro- and Nanoplastics Drive Pulmonary Fibrosis via FXR-YAP
2026-05-01
This study rigorously compares the pulmonary toxicity of microplastics and nanoplastics of varying polymers and sizes, demonstrating that both particle size and composition critically modulate fibrogenic and inflammatory responses in lung tissue. Mechanistic evidence implicates dysregulation of the FXR-YAP1 axis as a central pathway, with polystyrene nanoplastics exerting the most pronounced effects—findings that refine environmental risk assessment and mechanistic toxicology.
-
Differential Shh, Fgf10, and Fgfr2 Expression Shapes Penile
2026-04-30
This study dissects species-specific penile development by comparing Shh, Fgf10, and Fgfr2 expression in guinea pigs and mice. The findings clarify mechanisms underlying urethral groove and prepuce formation, with implications for understanding human genital morphogenesis.